Pantheon Medical manufactures speciality orthopaedic surgery products and tools for foot and ankle surgeries. Credit: CMSRC.

Integrated healthcare company Generex Biotechnology has signed a letter of intent (LOI) to acquire surgical devices firm Pantheon Medical – Foot & Ankle.

The deal covers all assets, including business operations, accounts receivable and inventory, contracts, and a US Food and Drug Administration (FDA) letter for balanced plating system.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Under the terms of the agreement, Generex will pay $1.4m worth of its stock, along with additional cash and stock consideration on reaching select sales and profit milestones.

Founded in 2014, Pantheon Medical manufactures speciality orthopaedic surgery products and tools such as screws, plates, implants and anchors for foot and ankle surgeries.

“Under the terms of the agreement, Generex will pay $1.4m worth of its stock, along with additional cash and stock consideration on reaching select sales and profit milestones.”

Generex expects the acquisition to boost its commercial product portfolio into the surgical field.

Pantheon Medical– Foot & Ankle CEO Travis Bird said: “Partnering with Generex will enable us to expedite Pantheon’s ability to build a manufacturing company with proprietary product lines that offer convenience and cost-effectiveness to physicians.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We are already seeing significant uptake in the marketplace with our ‘one stop shop’ approach to orthopaedic surgery, and the new product lines will expand our market reach.”

Over the coming three years, Pantheon Medical intends to develop multiple new product lines, including cannulated surgical screws, surgical staples and a Hammertoe System.

Generex Biotechnology CEO Joe Moscato said: “The acquisition of Pantheon expands the commercial product portfolio of Generex into the surgical field, adding revenues and profits with their current product line and significant upside opportunities for new FDA-approved product introductions over the next several years.

“Our MSO partners, many of whom are orthopaedic surgeons and podiatrists, will immediately benefit from Pantheon’s Foot & Ankle surgery kit.”

The company is currently working on completing the due diligence on the acquisition, which is expected to be closed in the coming weeks.